Literature DB >> 9230428

Familial Parkinson's disease. The awakening of alpha-synuclein.

M Goedert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9230428     DOI： 10.1038/40767

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  22 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.

Authors:  Kunikazu Tanji; Fumiaki Mori; Katsumi Kito; Akiyoshi Kakita; Junsei Mimura; Ken Itoh; Hitoshi Takahashi; Tetsu Kamitani; Koichi Wakabayashi
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

3.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice.

Authors:  Amanda N Sacino; Mieu Brooks; Michael A Thomas; Alex B McKinney; Nicholas H McGarvey; Nicola J Rutherford; Carolina Ceballos-Diaz; Janice Robertson; Todd E Golde; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2014-05       Impact factor: 17.088

4.  Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils.

Authors:  Jacob I Ayers; Mieu M Brooks; Nicola J Rutherford; Jasie K Howard; Zachary A Sorrentino; Cara J Riffe; Benoit I Giasson
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts.

Authors:  Jacob I Ayers; Cara J Riffe; Zachary A Sorrentino; Jeffrey Diamond; Eric Fagerli; Mieu Brooks; Ahmad Galaleldeen; P John Hart; Benoit I Giasson
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system.

Authors:  V L Buchman; H J Hunter; L G Pinõn; J Thompson; E M Privalova; N N Ninkina; A M Davies
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

8.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.

Authors:  Hui-Ming Gao; Paul T Kotzbauer; Kunihiro Uryu; Susan Leight; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2008-07-23       Impact factor: 6.167

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.